Evidence map›Paper›PMID 26954065›Full record

ArticleClinical genetics2016

A de novo frameshift in HNRNPK causing a Kabuki-like syndrome with nodular heterotopia.

L Lange, A T Pagnamenta, S Lise, S Clasper, H Stewart, E S Akha, G Quaghebeur, S J L Knight, D A Keays, J C Taylor and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genetic and Phenotypic Spectrum ofDiagnostics (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas.Journal of the National Cancer Institute · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

L LangeNational Institute for Health Research Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
A T PagnamentaNational Institute for Health Research Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
S LiseNational Institute for Health Research Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
S ClasperOxford Regional Genetics Service, Oxford Radcliffe Hospitals NHS Trust, The Churchill Hospital, Oxford, UK.
H StewartDepartment of Clinical Genetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
E S AkhaNational Institute for Health Research Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
G QuaghebeurDepartment of Neuroradiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
S J L KnightNational Institute for Health Research Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
D A KeaysInstitute of Molecular Pathology, Vienna, Austria.
J C TaylorNational Institute for Health Research Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
U KiniDepartment of Clinical Genetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Centre for Human Genetics · GBOxford University Hospitals NHS Trust · GBNational Institute for Health Research · GBChurchill Hospital · GBResearch Institute of Molecular Pathology · AT

Funding

Wellcome Trust 090532/Z/09/
6 · The paper itself

Abstract

Kabuki syndrome is a heterogeneous condition characterized by distinctive facial features, intellectual disability, growth retardation, skeletal abnormalities and a range of organ malformations. Although at least two major causative genes have been identified, these do not explain all cases. Here we describe a patient with a complex Kabuki-like syndrome that included nodular heterotopia, in whom testing for several single-gene disorders had proved negative. Exome sequencing uncovered a de novo c.931_932insTT variant in HNRNPK (heterogeneous nuclear ribonucleoprotein K). Although this variant was identified in March 2012, its clinical relevance could only be confirmed following the August 2015 publication of two cases with HNRNPK mutations and an overlapping phenotype that included intellectual disability, distinctive facial dysmorphism and skeletal/connective tissue abnormalities. Whilst we had attempted (unsuccessfully) to identify additional cases through existing collaborators, the two published cases were 'matched' using GeneMatcher, a web-based tool for connecting researchers and clinicians working on identical genes. Our report therefore exemplifies the importance of such online tools in clinical genetics research and the benefits of periodically reviewing cases with variants of unproven significance. Our study also suggests that loss of function variants in HNRNPK should be considered as a molecular basis for patients with Kabuki-like syndrome.

Indexed as

Abnormalities, MultipleBase SequenceDevelopmental DisabilitiesExomeFaceFemaleFrameshift MutationHematologic DiseasesHeterogeneous-Nuclear Ribonucleoprotein KHumansIntellectual DisabilityMaleNervous System MalformationsRibonucleoproteinsVestibular DiseasesHeterogeneous-Nuclear Ribonucleoprotein KHNRNPK protein, humanRibonucleoproteinsexomeheterotopiaHNRNPKKabuki

Identifiers

PMID26954065
PMCPMC5006848
OpenAlexW2293819947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.